182 related articles for article (PubMed ID: 34797618)
21. SARS-CoV-2 infection prevention and control measures in Belgian schools between December 2020 and June 2021 and their association with seroprevalence: a cross-sectional analysis of a prospective cohort study.
Callies M; Kabouche I; Desombere I; Merckx J; Roelants M; Vermeulen M; Duysburgh E
BMC Public Health; 2023 May; 23(1):898. PubMed ID: 37194008
[TBL] [Abstract][Full Text] [Related]
22. High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study.
Bruggmann P; Senn O; Frei A; Puhan MA; Fehr J; Falcato L
Swiss Med Wkly; 2022 Jan; 152():w30122. PubMed ID: 35019254
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 seroprevalence and determinants for salivary seropositivity among pupils and school staff: a prospective cohort study.
Merckx J; Callies M; Kabouche I; Desombere I; Duysburgh E; Roelants M
Epidemiol Infect; 2023 Apr; 151():e75. PubMed ID: 37092673
[TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 Infection and Antibody Seroprevalence among UK Healthcare Professionals Working with Cancer Patients during the First Wave of the COVID-19 Pandemic.
Favara DM; McAdam K; Cooke A; Bordessa-Kelly A; Budriunaite I; Bossingham S; Houghton S; Doffinger R; Ainsworth N; Corrie PG
Clin Oncol (R Coll Radiol); 2021 Oct; 33(10):667-675. PubMed ID: 33941453
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
Popova AY; Smirnov VS; Andreeva EE; Babura EA; Balakhonov SV; Bashketova NS; Bugorkova SA; Bulanov MV; Valeullina NN; Vetrov VV; Goryaev DV; Detkovskaya TN; Ezhlova EB; Zaitseva NN; Istorik OA; Kovalchuk IV; Kozlovskikh DN; Kombarova SY; Kurganova OP; Lomovtsev AE; Lukicheva LA; Lyalina LV; Melnikova AA; Mikailova OM; Noskov AK; Noskova LN; Oglezneva EE; Osmolovskaya TP; Patyashina MA; Penkovskaya NA; Samoilova LV; Stepanova TF; Trotsenko OE; Totolian AA
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452512
[TBL] [Abstract][Full Text] [Related]
26. Escalating spread of SARS-CoV-2 infection after school reopening among students in hotspot districts of Oromia Region in Ethiopia: Longitudinal study.
Gobena D; Kebede Gudina E; Yilma D; Girma T; Gebre G; Gelanew T; Abdissa A; Mulleta D; Sarbessa T; Asefa H; Woldie M; Shumi G; Kenate B; Kroidl A; Wieser A; Eshetu B; Degfie TT; Mekonnen Z
PLoS One; 2023; 18(2):e0280801. PubMed ID: 36735689
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 transmissions in students and teachers: seroprevalence follow-up study in a German secondary school in November and December 2020.
Armann JP; Kirsten C; Galow L; Kahre E; Haag L; Dalpke A; Lück C; Berner R
BMJ Paediatr Open; 2021; 5(1):e001036. PubMed ID: 34192197
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: Prospective, national observational cohort surveillance, July-December 2020, England.
Mensah AA; Sinnathamby M; Zaidi A; Coughlan L; Simmons R; Ismail SA; Ramsay ME; Saliba V; Ladhani SN
J Infect; 2021 Apr; 82(4):67-74. PubMed ID: 33639175
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and Risk Factors Associated With Self-reported Psychological Distress Among Children and Adolescents During the COVID-19 Pandemic in China.
Qin Z; Shi L; Xue Y; Lin H; Zhang J; Liang P; Lu Z; Wu M; Chen Y; Zheng X; Qian Y; Ouyang P; Zhang R; Yi X; Zhang C
JAMA Netw Open; 2021 Jan; 4(1):e2035487. PubMed ID: 33496797
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020.
Fontanet A; Tondeur L; Grant R; Temmam S; Madec Y; Bigot T; Grzelak L; Cailleau I; Besombes C; Ungeheuer MN; Renaudat C; Perlaza BL; Arowas L; Jolly N; Pellerin SF; Kuhmel L; Staropoli I; Huon C; Chen KY; Crescenzo-Chaigne B; Munier S; Charneau P; Demeret C; Bruel T; Eloit M; Schwartz O; Hoen B
Euro Surveill; 2021 Apr; 26(15):. PubMed ID: 33860747
[TBL] [Abstract][Full Text] [Related]
31. Staff SARS-CoV-2 Seroprevalence and Mental Health as Key Factors in University Response to COVID-19 Pandemic.
Lopes DG; Henriques AR; Santos-Dias M; Nunes-da-Silva C; Gonçalves J; de Sousa RD; Abdulghani S; Eletério J; Braga SJ; Soares H; Branco JC; Canhão H; Rodrigues AM
Front Public Health; 2021; 9():689919. PubMed ID: 34222187
[No Abstract] [Full Text] [Related]
32. Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.
Angulo FJ; Finelli L; Swerdlow DL
JAMA Netw Open; 2021 Jan; 4(1):e2033706. PubMed ID: 33399860
[TBL] [Abstract][Full Text] [Related]
33. Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021.
Sorg AL; Bergfeld L; Jank M; Corman V; Semmler I; Goertz A; Beyerlein A; Verjans E; Wagner N; Von Bernuth H; Lander F; Weil K; Hufnagel M; Spiekerkoetter U; Chao CM; Naehrlich L; Muntau AC; Schulze-Sturm U; Hansen G; Wetzke M; Jung AM; Niehues T; Fricke-Otto S; Von Both U; Huebner J; Behrends U; Liese JG; Schwerk C; Drosten C; Von Kries R; Schroten H
Nat Commun; 2022 Jun; 13(1):3128. PubMed ID: 35668073
[TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2 Infection, Risk Perception, Behaviour and Preventive Measures at Schools in Berlin, Germany, during the Early Post-Lockdown Phase: A Cross-Sectional Study.
Hommes F; van Loon W; Thielecke M; Abramovich I; Lieber S; Hammerich R; Gehrke-Beck S; Linzbach E; Schuster A; von dem Busche K; Theuring S; Gertler M; Martinez GE; Richter J; Bergmann C; Bölke A; Böhringer F; Mall MA; Rosen A; Krannich A; Keller J; Bethke N; Kurzmann M; Kurth T; Kirchberger V; Seybold J; Mockenhaupt FP; Study Group B
Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33800392
[TBL] [Abstract][Full Text] [Related]
35. Is living in a household with children associated with SARS-CoV-2 seropositivity in adults? Results from the Swiss national seroprevalence study Corona Immunitas.
Blankenberger J; Kaufmann M; Albanese E; Amati R; Anker D; Camerini AL; Chocano-Bedoya P; Cullati S; Cusini A; Fehr J; Harju E; Kohler P; Kriemler S; Michel G; Rodondi N; Rodondi PY; Speierer A; Tancredi S; Puhan MA; Kahlert CR;
BMC Med; 2022 Jun; 20(1):233. PubMed ID: 35725472
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 serological findings and exposure risk among employees in school and retail after first and second wave COVID-19 pandemic in Oslo, Norway: a cohort study.
Moe AG; Eriksen MB; Schjølberg T; Haugen F
Int J Occup Med Environ Health; 2022 Oct; 35(5):537-547. PubMed ID: 35770786
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020.
Gidding HF; Machalek DA; Hendry AJ; Quinn HE; Vette K; Beard FH; Shilling HS; Hirani R; Gosbell IB; Irving DO; Hueston L; Downes M; Carlin JB; O'Sullivan MV; Dwyer DE; Kaldor JM; Macartney K
Med J Aust; 2021 Mar; 214(4):179-185. PubMed ID: 33538019
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort study.
Mortgat L; Verdonck K; Hutse V; Thomas I; Barbezange C; Heyndrickx L; Fischer N; Vuylsteke B; Kabouche I; Ariën KK; Desombere I; Duysburgh E
BMJ Open; 2021 Jun; 11(6):e050824. PubMed ID: 34187832
[TBL] [Abstract][Full Text] [Related]
39. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
[TBL] [Abstract][Full Text] [Related]
40. Heterogenous transmission and seroprevalence of SARS-CoV-2 in two demographically diverse populations with low vaccination uptake in Kenya, March and June 2021.
Munywoki PK; Bigogo G; Nasimiyu C; Ouma A; Aol G; Oduor CO; Rono S; Auko J; Agogo GO; Njoroge R; Oketch D; Odhiambo D; Odeyo VW; Kikwai G; Onyango C; Juma B; Hunsperger E; Lidechi S; Ochieng CA; Lo TQ; Munyua P; Herman-Roloff A
Gates Open Res; 2023; 7():101. PubMed ID: 37990692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
